NAD+ × Nextgen Peptides — Lab Test, April 2026
ILS Laboratories publishes a public verification portal. Any test attributed to this lab can be looked up and confirmed directly with the lab — so this result doesn't rest on our review alone.
This certificate carries no lookup code.
Test results
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Independent HPLC purity analysis of NAD+ from Nextgen Peptides, performed by ILS Laboratories on April 21, 2026. Reported purity: 99.55%. Net content: 522.64 mg against 500 mg labeled (105% of label). Endotoxins: NMT 0.05 EU/mL. Batch NAD-08. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion